Blood Test that Can Identify Laminin 332 Launched
KSL Beutner Laboratories (Beutner) has launched an IIF serum blood test in the U.S. that positively identifies laminin 332.
Read MorePosted by Chris Wolski | Aug 12, 2022 | Allergy & Autoimmune |
KSL Beutner Laboratories (Beutner) has launched an IIF serum blood test in the U.S. that positively identifies laminin 332.
Read MorePosted by Andy Lundin | Aug 1, 2022 | Cancer |
The Alliance for Clinical Trials in Oncology announced a new study that aims to assess the utility of early cancer detection blood tests.
Read MorePosted by Andy Lundin | Jul 20, 2022 | Cancer |
A key genetic mutation that occurs early on in cancer alters RNA “dark matter” and causes the release of RNA biomarkers for cancer detection.
Read MorePosted by Andy Lundin | Jul 18, 2022 | Cancer |
A research lab reported using chaperonin as a new marker for cancer cells in blood that provides a clearer indication of spreading cancer.
Read MorePosted by Chris Wolski | Jul 13, 2022 | Lung Cancer |
Researchers have found a blood biomarker that can complement LDCT by distinguishing NSCLC from benign nodules without an invasive biopsy.
Read More